Latest news with #Blaser
Yahoo
3 days ago
- Business
- Yahoo
QDEL Q1 Earnings Call: Cost Savings and Tariff Mitigation Anchor 2025 Outlook
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) met Wall Street's revenue expectations in Q1 CY2025, but sales fell by 2.6% year on year to $692.8 million. The company's outlook for the full year was close to analysts' estimates with revenue guided to $2.71 billion at the midpoint. Its non-GAAP profit of $0.74 per share was 24.9% above analysts' consensus estimates. Is now the time to buy QDEL? Find out in our full research report (it's free). Revenue: $692.8 million vs analyst estimates of $689.8 million (2.6% year-on-year decline, in line) Adjusted EPS: $0.74 vs analyst estimates of $0.59 (24.9% beat) Adjusted EBITDA: $159.8 million vs analyst estimates of $149.4 million (23.1% margin, 7% beat) The company reconfirmed its revenue guidance for the full year of $2.71 billion at the midpoint Management reiterated its full-year Adjusted EPS guidance of $2.32 at the midpoint EBITDA guidance for the full year is $595 million at the midpoint, in line with analyst expectations Operating Margin: 4.7%, up from -247% in the same quarter last year Market Capitalization: $2.09 billion QuidelOrtho's first quarter results were shaped by growth in its core laboratories segment, stable immunohematology performance, and a robust flu testing season, offset by lower COVID-related and donor screening revenues. CEO Brian Blaser highlighted that the labs business, now over half of total revenue, delivered 7% year-over-year growth, while immunohematology grew 4%. Blaser credited the company's ongoing cost reduction initiatives—including staffing cuts and procurement efficiencies—for a 450 basis point improvement in adjusted EBITDA margin. The company also benefited from increased sales of its COVID-flu combination tests, which Blaser described as showing 'very stable performance,' helping mitigate the broader decline in COVID-only testing volumes. Management characterized the quarter as further evidence that its 2024 operational changes are positively impacting profitability and business stability. Looking ahead, QuidelOrtho's management sees its narrowed set of strategic priorities—expanding platform content, margin improvement, and targeted commercial execution—as key drivers for 2025. Blaser emphasized the company's plans to fully offset anticipated tariff headwinds, noting, 'We believe the incremental actions we are taking are sufficient to fully offset the tariff impacts as they stand today.' The company expects recurring revenues from consumables to underpin stability, supported by a diversified manufacturing footprint. CFO Joe Busky added that visibility into labs and immunohematology growth in China supports a mid- to high-single-digit outlook for that market, assuming the tariff environment remains unchanged. Management remains focused on delivering cost savings and maintaining profitability targets, while monitoring for potential shifts in COVID and flu testing demand. Management attributed the quarter's performance to solid growth in non-COVID segments, benefits from prior cost-reduction actions, and strong execution in the labs and flu testing businesses. Labs business momentum: Core laboratories led growth, with consistent demand in clinical chemistry and immunoassay testing, representing over half of Q1 revenue. Immunohematology stability: The immunohematology segment maintained its global leadership with steady 4% growth, particularly benefiting from strength in the Europe, Middle East, and Africa region. Flu and combo testing resilience: Sales of flu tests and the COVID-flu combination test remained strong, offsetting the expected decline in pure COVID testing. The durability of the combo product contributed to recurring revenue streams. Cost savings initiatives: Operational changes—including staff reductions, procurement efficiencies, and expense controls—were credited with expanding non-GAAP margins and reducing operating costs. Management expects further incremental savings in 2025. Tariff mitigation efforts: The company outlined a multi-pronged strategy to counter expected $30–40 million tariff headwinds. Actions include re-sourcing materials, adjusting supply chains, selective pricing, and ongoing inventory repositioning. Management stated these steps are expected to fully neutralize tariff effects on financial results. QuidelOrtho's outlook for 2025 is anchored by recurring revenue growth in core segments, ongoing cost control, and strategies to manage external headwinds such as tariffs. Recurring consumables revenue: Management highlighted that over 90% of sales stem from consumables, providing a stable revenue foundation less susceptible to one-time instrument sales volatility. The company expects this model to drive consistent growth, especially in labs and immunohematology. Cost discipline and savings: The company is on track to realize the remainder of its $100 million annualized cost savings program, with additional procurement and cash flow initiatives expected to deliver a further $30–50 million in savings during 2025. These efforts are intended to support margin expansion even as the company faces external cost pressures. Tariff and macro environment management: Expected tariff headwinds are being addressed through supply chain adjustments, selective price increases, and cost reductions. Management expressed confidence that these measures will allow QuidelOrtho to maintain its guidance even if the tariff situation evolves, but noted that ongoing monitoring is required due to the dynamic nature of global trade policy. In the coming quarters, the StockStory team will be watching (1) the pace at which cost savings and procurement initiatives translate into sustained margin gains, (2) the impact of tariff mitigation actions on both supply chain flexibility and pricing power, and (3) any changes in demand for respiratory testing—particularly the COVID-flu combination test. Progress on Savanna respiratory panel submission and broader product pipeline developments will also serve as key signposts for tracking execution. QuidelOrtho currently trades at a forward P/E ratio of 12.1×. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Yahoo
25-04-2025
- Yahoo
Green Bay woman accused of giving drugs to hospitalized boyfriend, charged with homicide
(WFRV) – A Green Bay woman had her bail set at $25,000 after being charged with homicide and allegations of bringing drugs to her hospitalized boyfriend. According to a criminal complaint obtained by Local 5, 55-year-old Joelle Blaser is charged with homicide for her alleged role in the overdose death of her longtime boyfriend. Back on September 2, 2024, officers were sent to a rehabilitation center for a report of a man pulseless and breathless. Relentless search for missing Wisconsin woman continues through dangerous terrain, officers share message Staff at the center reportedly told authorities the man's significant other, identified as Blaser, was banned from the facility after allegedly giving him five Xanax a few days earlier. The complaint included text messages between Blaser and the victim that police claim show Blaser referencing drugs. The autopsy of the victim was listed as 'combined drug toxicity', and the fentanyl level was confirmed to be significantly high. On October 9, 2024 authorities spoke with Blaser. She said her and the victim were in a 14-year romantic relationship, the complaint said. Blaser reportedly denied bringing the victim drugs while he was hospitalized. On April 23, 2025, around 10:40 a.m., authorities took Blaser into custody. The complaint says Blaser admitted to leaving a bottle containing Xanax and fentanyl for the victim. She allegedly said the victim was going through withdrawals and was apprehensive about bringing drugs to the hospital, the complaint said. Blaser is charged with first degree reckless homicide and faces up to 60 years in prison. FBI arrests a Wisconsin judge accused of helping a man evade immigration authorities Court records show she was in court on April 24 for her initial appearance. Her cash bond was set at $25,000. Blaser is set to be back in court on May 21 for her adjourned initial appearance. No additional information was provided. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
19-03-2025
- Yahoo
Missing Golden Retriever of West Springfield, Remi found dead, 'family finally has some closure'
WEST SPRINGFIELD, Mass. (WWLP) – Remi, a missing Golden Retriever who was last seen in January was found dead in West Springfield on Tuesday. The 7-month-old puppy of West Springfield was last seen on January 3rd in the Cooks Park playground area and was wearing a red collar with white bones on it with his leash still attached. Many community members rallied to help the Blaser family find him. West Springfield Police and Hawkeye Aerial Systems used their drones to conduct searches in areas where he may have been hiding without any success. A reward was also set up in the chance that someone may have taken him in thinking he was a stray. Family in West Springfield searching for missing Golden Retriever Police urged homeowners to check their properties and to be on the lookout. 'Check your property, look under the deck, look behind the shed, look in the bushes. Remi could be trapped or stuck with the leash,' said Sergeant Joe LaFrance of the West Springfield Police Department. The family also worked with Missing Mutts Search & Rescue, along with Missing Dogs of Massachusetts. On Wednesday morning, the nonprofit organization, Missing Mutts Search & Rescue of Somers, Connecticut posted on Facebook that Remi was found dead in a West Springfield backyard. According to the post, Remi was found on Tuesday behind a garage, between a fence and under a pile of thick brush. When he was brought to a veterinarian where they determined he may have been hit by a vehicle and ran to hide in a small space. They also indicated that he had been deceased most likely since the first couple of days he was missing. The sad, unfortunate news has brought closure to the Blaser family and stated to Missing Mutts Search & Rescue, that they 'thank everyone for EVERY SINGLE OUNCE of love, prayers, and searching of the many areas we needed to clear.' West Springfield Police Sergeant Joe LaFrance told 22News that the department is 'very sorry to hear the news about Remi, but it's good the family finally has some closure.' WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
05-02-2025
- Sport
- Yahoo
Aledo names first Parks & Rec Director
Aledo has hired its first Parks and Recreation Director. Troy Blaser has been hired at the new Parks and Recreation Director to lead the city's parks and recreational programs. He officially began his role on January 2 and has already shown his passion for creating meaningful recreational opportunities for all residents. Blaser is an Aledo native and graduated from Aurora University with a Bachelor of Science in Recreation Administration. He has spent over 15 years enriching communities with innovative recreation programs. His career includes leadership roles with the City of Wilson Parks and Recreation, Nash County Parks and Recreation and the Town of Garner Parks and Recreation in North Carolina. He's won awards including the Young Professional Award from the North Carolina Recreation & Park Association and a leader in organizing youth sports, special events and community-wide initiatives. Blaser will manage and expand the city's recreational offerings. 'I think there's a lot of potential here. The people want it,' he said. 'I had a great feeling about the role and this opportunity. I was excited to take it.' One of his biggest priorities is overseeing the development of the Aledo Aquatics Center. This state-of-the-art facility will transform the city's recreational offerings, giving residents a place to gather, exercise and relax. 'It's exciting. It's an awesome opportunity for Aledo,' said Blaser. 'It's a beautiful looking facility. I grew up going to the old swimming pool, and the new facility is a great opportunity for our city.' Blaser has experience in coordinating youth athletics programs, planning large-scale events like daddy-daughter dances and Halloween festivals, and served as a miniature train conductor for special community occasions. 'The right people are in place to make good things happen. We are looking to bring more tournaments to Aledo and give opportunities for kids to learn, play and grow,' said Blaser. The new position was created from a collaborative effort among the City of Aledo, the Aledo Park District and the Mercer County Family YMCA. 'His addition to our staff perfectly captures the city's commitment to fostering partnerships that prioritize the well-being of our residents,' said Chris Hagloch, mayor of Aledo. 'We are excited to see Troy transform Aledo's recreational offerings. He will allow us to better serve our community.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
